CC BY 4.0 UnportedCirillo, G.Vittorio, O.Kunhardt, D.Valli, E.Voli, F.Farfalla, A.Curcio, M.Spizzirri, U.G.Hampel, S.2020-07-182020-07-182019https://doi.org/10.34657/3612https://oa.tib.eu/renate/handle/123456789/4983A hybrid system composed of multi-walled carbon nanotubes coated with chitosan was proposed as a pH-responsive carrier for the vectorization of methotrexate to lung cancer. The effective coating of the carbon nanostructure by chitosan, quantified (20% by weight) by thermogravimetric analysis, was assessed by combined scanning and transmission electron microscopy, and X-ray photoelectron spectroscopy (N1s signal), respectively. Furthermore, Raman spectroscopy was used to characterize the interaction between polysaccharide and carbon counterparts. Methotrexate was physically loaded onto the nanohybrid and the release profiles showed a pH-responsive behavior with higher and faster release in acidic (pH 5.0) vs. neutral (pH 7.4) environments. Empty nanoparticles were found to be highly biocompatible in either healthy (MRC-5) or cancerous (H1299) cells, with the nanocarrier being effective in reducing the drug toxicity on MRC-5 while enhancing the anticancer activity on H1299.enghttps://creativecommons.org/licenses/by/4.0/620Lung cancerMethotrexateMulti-walled carbon nanotubesNanohybridsPH responsivityBiocompatibilityBiological organsChitosanControlled drug deliveryDiseasesHigh resolution transmission electron microscopyHybrid systemsNanotubesScanning electron microscopyTargeted drug deliveryThermogravimetric analysisX ray photoelectron spectroscopyAnticancer activitiesCarbon NanostructuresLung CancerLung cancer cellsMethotrexateNanohybridsResponsivityScanning and transmission electron microscopyMultiwalled carbon nanotubes (MWCN)Article